CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood transplants expanded to thousands in new access study
Disease control Recruiting nowThis study gives people with blood cancers, immune disorders, and other serious diseases access to unlicensed cord blood units for transplant. It includes both children and adults of any age. The main goal is to see how well the body recovers its white blood cells after the trans…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New cord blood transplant method could boost survival in tough blood cancers
Disease control Recruiting nowThis study is testing an improved method for cord blood transplants in adults with high-risk blood cancers like leukemia and lymphoma. The goal is to see if this optimized approach helps patients live longer and have fewer side effects. About 54 participants will receive the tran…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:23 UTC